| Systematic (IUPAC) name | |
|---|---|
| (4S,5R,6R)-5-acetamido-4-carbamimidamido-6-[(1R,2R)-3-hydroxy-2-methoxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Inhalation |
| Identifiers | |
| CAS number | 203120-17-6 |
| ATC code | None |
| PubChem | CID 502272 |
| ChemSpider | 439182 |
| UNII | B408IW3GL5 |
| ChEMBL | CHEMBL466246 |
| Chemical data | |
| Formula | C13H22N4O7 |
| Mol. mass | 346.33638 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| (what is this?) (verify) |
|
Laninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B.[1] It is currently in Phase III clinical trials.[2]
|
||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||